Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$9.10 +0.80 (+9.57%)
At close: Sep 30, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Tax Provisions (2024 - 2026)

Updated

Eupraxia Pharmaceuticals (EPRX) recorded Tax Provisions of -$30,381 in the quarter ended Jun 30, 2026, compared with -$5,581 a year earlier.

Analysis

Eupraxia Pharmaceuticals (EPRX) Tax Provisions (2024 - 2026) Analysis & Trends

On a TTM basis, Eupraxia Pharmaceuticals' Tax Provisions came in at -$52,661 as of Jun 30, 2026; for the year ended Dec 31, 2025, it was -$19,091.

  • Across earlier years, Tax Provisions came in at -$1,804 in the year ended Dec 31, 2024 and -$36,423 in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.21 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 662.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -1.01 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -291.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 393.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 242.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -407.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 292.00 Mn
10 Eupraxia Pharmaceuticals 332.04 Mn 330.43 Mn - -30,381.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -30,381.00
Mar 31, 2026 -13,905.00
Jun 30, 2025 -5,581.00
Mar 31, 2025 -2,794.00
Jun 30, 2024 5,000.00
Mar 31, 2024 -5,000.00
API Access

Eupraxia Pharmaceuticals Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=EPRX&period=max&api_key=YOUR_API_KEY